Home/ Supplements/ Vitamin K/ K2-45

K2-45

product on market Capsule XYMOGEN Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 100% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

✨ AI-generated · Qwen 3.6 · grounded in 1 source · methodology

Vitamin K2 is supported by strong evidence for its role in supporting bone health and cardiovascular function by regulating calcium deposition. Research indicates it works synergistically with vitamin D to improve bone mineral density. The overall evidence coverage for this specific formulation is limited.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for K2-45
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Capsule(s)
Serving Size
60
Servings
Vitamin
Product Type
100%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

45 mcg
Within RDA (0.4× RDA) 275 studies (A:9, B:175)

Other Ingredients

Microcrystalline Cellulose Hypromellose Water Stearic Acid Magnesium Stearate Silica
Claims

Label Claims — Verification

Unverified Nutrient
Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Directions: Take one capsule with a meal, one to two times daily, or as directed by your healthcare professional.

Warnings & Precautions

Consult your healthcare professional prior to use.

Individuals taking blood thinners or other medication should discuss potential interactions with their healthcare professional.

Do not use if tamper seal is damaged.

Storage: Keep closed in a cool, dry place out of reach of children.

Formulation Notes

K2-45, derived from non-GMO soybeans fermented with Bacillus subtilis natto, is the most bioavailable and bioactive form of supplemental vitamin K2 available. Historical use and numerous studies have confirmed safety and efficacy for bone and heart health.

Formulated to exclude: Wheat, gluten, yeast, soy protein, animal and dairy products, fish, shellfish, peanuts, tree nuts, egg, sesame, ingredients derived from genetically modified organisms (GMOs), artificial colors, artificial sweeteners, and artificial preservatives.

Natural Vitamin K2 as MK-7

Vegetarian caps

Additional Information

Storage: Keep closed in a cool, dry place out of reach of children.

ePV (ePedigree Verification)

Third-Party Verified GMP Compliant

Scan to learn more! This package is completely recyclable

Metadata

Product Details

UPC / SKU8 71149 00317 3
DSLD Entry Date2024-12-21
Product TypeVitamin
FormCapsule
BrandXYMOGEN
DSLD ID303712
Data Updated2026-04-11
Research

Research Evidence

332
Research Sources
59
Avg Quality
220
Meta Analysis
56
Systematic Review
30
Rct
16
Clinical Trial
3
Guideline
3
Regulatory Source
1
Narrative Review
1
Other
1
Openfda Safety
A Duration of treatment with vitamin K antagonists in symptomatic venous thromboembolism
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
A Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome
Meta Analysis The Cochrane database of systematic reviews 2017 PubMed DOI
A Anticoagulants (extended duration) for prevention of venous thromboembolism following total hip or knee replacement or hip fracture repair
Meta Analysis The Cochrane database of systematic reviews 2016 PubMed DOI
A Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
A Direct factor Xa inhibitors versus low molecular weight heparins or vitamin K antagonists for prevention of venous thromboembolism in elective primary hip or knee replacement or hip fracture repair
Meta Analysis The Cochrane database of systematic reviews 2025 PubMed DOI
A Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Antiplatelet agents and anticoagulants for hypertension
Systematic Review The Cochrane database of systematic reviews 2022 PubMed DOI
A Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy
Meta Analysis The Cochrane database of systematic reviews 2012 PubMed DOI
A Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
Meta Analysis The Cochrane database of systematic reviews 2013 PubMed DOI
A Anticoagulation for the long-term treatment of venous thromboembolism in patients with cancer
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
View all evidence for Vitamin K →
Compare

Similar Products

Vitamin D Synergy with Vitamin K1
Designs for Health · Capsule
100
Vitamin D Synergy with Vitamin K1
Designs for Health · Capsule
100
Natural Vitamin K2 45 mcg
Doctor's Best · Capsule
100
K 100 mcg
Thompson · Capsule
100
Vitamin K2 300 mcg MK-7
Innerzyme · Capsule
100
View all Vitamin K products →
Vitamin K research Best Vitamin K All Vitamin K products More from XYMOGEN View on NIH DSLD →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.